Alto Neuroscience, Inc. (ANRO)
21.22
-0.32
(-1.49%)
USD |
NYSE |
May 22, 16:00
21.21
-0.01
(-0.05%)
After-Hours: 20:00
Alto Neuroscience EPS Diluted (Quarterly) : -0.7976 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| NRX Pharmaceuticals, Inc. | -0.0442 |
| LB Pharmaceuticals, Inc. | -0.6747 |
| ANI Pharmaceuticals, Inc. | 1.276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.24M |
| Total Expenses (Quarterly) | 26.24M |
| Enterprise Value | 504.15M |
| Earnings Yield | -11.70% |
| Normalized Earnings Yield | -11.65 |